Cooperate

HOME  Cooperate  Out-Licensing / In-Licensing
In-Licensing Solutions to Taiwan 

For pharmaceutical companies looking to enhance their product portfolios with novel and differentiated offerings, our inlicensing solutions provide access to a curated selection of high-potential products and technologies from global partners.

We are proud to have successfully launched more than 5 in-licensed products in Taiwan, in collaboration with our esteemed global partners. These products have made a significant impact on the healthcare landscape, positively affecting patient outcomes and driving business growth for our partnering pharmaceutical companies.

20230818165407M4gx



Out-Licensing Opportunities 
Explore our extensive portfolio of outlicensing opportunities, where we offer a diverse range of innovative pharmaceutical products and technologies. Our out-licensing solutions present lucrative options for companies seeking to expand their product offerings, strengthen market presence, and maximize revenue potential.

Rare Disease and Orphan Drug Opportunities
Access our curated selection of rare disease and orphan drug opportunities, addressing critical medical needs for underserved patient populations. In-licensing these specialized therapies can foster meaningful partnerships and strengthen your commitment to global health.

202308181655140rF1